Skip to main content

Table 3 Comparison of symptomatic DVT incidence rate between seroconverted and non-converted patients

From: Clinical relevance of heparin-PF4 complex antibody in DVT after total joint replacement

  Seroconverted Non-converted Odds ratio p-value
  n = 36 n = 68 (95%CI)  
  (%) (%)   
DVT incidence 11
(30.6%)
5
(7.4%)
5.5
(1.7–17.6%)
0.028